BAHAR, A. N. Et Al. 2024. AGK2, a SIRT2 inhibitor, ameliorates D-galactose-induced liver fibrosis by inhibiting fibrogenic factors.. Journal of biochemical and molecular toxicology , vol.38, no.11 .

BAHAR, A. N., Keskin-Aktan, A., Akarca-Dizakar, S. Ö., Sonugür, G., & AKBULUT, K. G., (2024). AGK2, a SIRT2 inhibitor, ameliorates D-galactose-induced liver fibrosis by inhibiting fibrogenic factors.. Journal of biochemical and molecular toxicology , vol.38, no.11.

BAHAR, ASLI Et Al. "AGK2, a SIRT2 inhibitor, ameliorates D-galactose-induced liver fibrosis by inhibiting fibrogenic factors.," Journal of biochemical and molecular toxicology , vol.38, no.11, 2024

BAHAR, ASLI N. Et Al. "AGK2, a SIRT2 inhibitor, ameliorates D-galactose-induced liver fibrosis by inhibiting fibrogenic factors.." Journal of biochemical and molecular toxicology , vol.38, no.11, 2024

BAHAR, A. N. Et Al. (2024) . "AGK2, a SIRT2 inhibitor, ameliorates D-galactose-induced liver fibrosis by inhibiting fibrogenic factors.." Journal of biochemical and molecular toxicology , vol.38, no.11.

@article{article, author={ASLI NUR BAHAR Et Al. }, title={AGK2, a SIRT2 inhibitor, ameliorates D-galactose-induced liver fibrosis by inhibiting fibrogenic factors.}, journal={Journal of biochemical and molecular toxicology}, year=2024}